Showing results (111-120 of 409) with videos related to
Sort By:
Pageof 41
Seminars in Thrombosis and Hemostasis|March 9, 2012
Infection and inflammation as risk factors for thrombosis and atherosclerosisMarcel Levi, Tom van der Poll, Marcus SchultzAustralian and New Zealand Journal of Public Health|April 28, 2004
Raising the profile of public health ethics in Australia: time for debateCraig L Fry, Anita Peerson, Anne-Marie ScullyBlood|March 2, 2026
Thrombotic thrombocytopenic purpura: celebrating 25 years of ADAMTS13Marie Scully, Matthew A Carter, Maryam Owais SubhanBMJ Case Reports|September 24, 2021
Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosisPujon Purkayastha, Charlie Mckechnie, Pallavi Kalkur, et al.British Journal of Haematology|August 24, 2006
The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpuraMarie Scully, Michael Gattens, Kate Khair, et al.Journal of Thrombosis and Thrombolysis|February 5, 2004
Sepsis and disseminated intravascular coagulationMarcel Levi, Evert de Jonge, Tom van der PollSeminars in Thrombosis and Hemostasis|February 16, 2006
Tissue factor in infection and severe inflammationMarcel Levi, Tom van der Poll, Hugo ten CateSeminars in Thrombosis and Hemostasis|September 30, 2009
Management strategies for optimal control of anticoagulation in patients with atrial fibrillationMarcel Levi, Olaf R de Peuter, Pieter W KamphuisenThe Journal of Allergy and Clinical Immunology|April 25, 2006
Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiencyMarcel Levi, Goda Choi, Charles Picavet, et al.Current Drug Targets|April 18, 2003
Anticoagulant therapy for acute lung injury or pneumoniaMarcus J Schultz, Marcel Levi, Tom van der PollPageof 41